Indication for Use
You are requesting treatment with a GLP-1 (Ozempic, Wegovy, or compounded semaglutide) or GIP/GLP-1 receptor agonist (Mounjaro, Zepbound, or compounded tirzepatide) medication as part of your treatment plan for the management of weight or obesity. These medications work by mimicking the action of incretin hormones, which help regulate blood sugar levels, promote feeling full, and reduce food intake.

Potential Benefits

Weight loss or weight management
Improved blood glucose control
Reduced cardiovascular risk
Potential improvement in overall metabolic health

Potential Side Effects
While these medications can be beneficial, they may also cause side effects. Although not common, these medications can result in emergency room visits, hospitalizations, or even death. Common and serious side effects include, but are not limited to:

Common Side Effects: Nausea, Vomiting, Diarrhea, Constipation, Decreased appetite, Indigestion
Serious Side Effects: Pancreatitis (inflammation of the pancreas), Hypoglycemia (low blood sugar), especially when used with other diabetes medications, Gallbladder disease (e.g., gallstones), Kidney problems, Allergic reactions (e.g., rash, itching, swelling), Gastroparesis (paralysis of the bowels)

Risks and Considerations

Pancreatitis: There is a risk of developing pancreatitis. If you experience severe abdominal pain, nausea, or vomiting, you should contact your healthcare provider immediately.
Thyroid Tumors: Animal studies have shown an increased risk of thyroid tumors with certain GLP-1 medications. Although this has not been confirmed in humans, please inform your healthcare provider if you have a history of thyroid cancer.
Hypoglycemia: When taken with other diabetes medications, particularly insulin or sulfonylureas, there is a risk of low blood sugar. It is important that your provider knows if any of these medications are added to your regimen.
Kidney Function: This medication may affect kidney function, particularly in patients with existing kidney disease. Regular monitoring of kidney function may be required.

Monitoring and Follow-up
You will require regular follow-up visits to monitor your response to the medication and to assess for any side effects. We may intermittently ask for full-body selfie images to ensure that your reported weight is consistent.